1. Division of Pharmaceutics and Biopharmaceutics, Faculty of Pharmaceutical Sciences, The University of British Columbia, Vancouver, British Columbia, Canada1;
2. ZymeTx, Inc., Oklahoma City, Oklahoma2; and
3. Aronex Pharmaceuticals, Inc., The Woodlands, Texas3